Clinical Trials Search
Clinical trials are important medical research studies that can ultimately advance the standard of care for all individuals who face cancer, both now and in the future. To accomplish this, it’s crucial to develop new and better strategies for the prevention, screening, diagnosis and treatment of various types of malignancies – and once these strategies are developed, they must be evaluated through controlled research studies. In fact, all of today’s most effective approaches are based on the results of past clinical trials.
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
As researchers study the effectiveness of promising new options as compared to those that are currently available, clinical trials offer participants unique opportunities to be among the first to benefit from recent scientific progress that has the potential to enhance both patient outcomes and quality of life. It is important to note that these studies are carefully designed to make the health and safety of every participant a top priority. Even so, clinical trials are not suitable for everyone, and participation is entirely voluntary.
At Moffitt Cancer Center, each patient’s treatment plan is individualized and collaboratively developed by a multispecialty team of experts who evaluate a number of factors to ensure the best possible strategy. Our patients have access to a full range of options, which may include clinical trials of new:
- Screening and diagnostic tests
- Imaging techniques
- Surgical procedures
- Chemotherapy drugs and drug combinations
- Radiation therapy delivery methods
- And more
With our robust portfolio of clinical trials - including breast cancer clinical trials, lung cancer clinical trials, skin cancer clinical trials and much more - Moffitt remains firmly established at the forefront of cancer research, and we have opportunities for many patients who are at different points in their cancer journeys. If our tumor board believes that a patient could potentially benefit from participation in a clinical trial, we will identify appropriate studies and fully educate the patient to help him or her make an informed choice about whether to enroll.
Of course, a decision to participate in a clinical trial is highly personal, and that decision ultimately belongs to the patient alone. Additionally, once a patient elects to participate, he or she can opt out at any time for any reason (or no reason at all). Patients who participate in clinical trials at Moffitt can have peace of mind in knowing that they are being closely and continually monitored by multiple experts who are committed to protecting their health, safety and well-being.